YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Data from Bayer's cardiovascular portfolio in heart failure and cardiac amyloidosis will be presented, including late-breaking data for investigational iodine 124 evuzamitide (I 124 evuzamitide) from a Phase III study in patients with susp…
Bayer BAYRY is moving to expand the addressable market for Kerendia (finerenone), with the FDA accepting the company's supplemental new drug application (sNDA) for adults with chronic kidney disease (CKD) without diabetes. The drug is a se…
Novartis NVS received a key regulatory win for Rhapsido (remibrutinib) in the United States, with the FDA approving the oral Bruton's tyrosine kinase (BTK) inhibitor for adults with symptomatic dermographism (SD) inadequately controlled by…
Bayer and actress Melissa Joan Hart are partnering to raise awareness about Lynkuet® (elinzanetant) 60mg capsules, a hormone-free prescription treatment for the reduction of moderate to severe hot flashes due to menopause,1 and encourage w…
Company Logo 135-Page Report Tracks Bayer and Merck's ADEMPAS (Riociguat) as the Leading Therapy as Combination Regimens and Balloon Pulmonary Angioplasty Reshape CTEPH Treatment Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- "Chronic Pulmonary…
Investing.com - The U.S. Food and Drug Administration accepted Bayer's supplemental New Drug Application for Kerendia (finerenone) to treat adults with chronic kidney disease without diabetes, the company announced Thursday. The applicatio…
Aktieselskabet Schouw & Co. Today, Schouw & Co. hosts a Capital Markets Day in Copenhagen, Denmark. The Capital Markets Day will focus, among other things, on the continued strength of the conglomerate model following the successful IPO of…
The supplemental New Drug Application (sNDA) was supported by results from the Phase III FIND-CKD trial investigating KERENDIA® (finerenone) in adults with chronic kidney disease (CKD) without diabetes who were also receiving background st…
NYKÖPING, SE / ACCESS Newswire / October 8, 2026 / CTT Systems AB (STO:CTT) - CTT Systems' Interim Report for Q3 2026 will be published on October 27, 2026, at 08.00 (CET) The presentation will be webcasted at 09:30 (CET). The report will…
Toshiba's ELERA® Self Service successfully deployed across Okay, Okay City, Spar Colruyt Group and Bio-Planet stores in Belgium BRUSSELS, October 08, 2026--(BUSINESS WIRE)--Toshiba Global Commerce Solutions today announced the successful d…
Jim Cramer sees one clear winner from Corteva, Inc. (NYSE:CTVA) latest breakup. During the October 2 episode of Mad Money, Cramer said he would be comfortable building a position in Vylor Inc. (NYSE:VYLR), the seed business spun off from C…
- Applying proprietary plastic-film technology to textiles to combine design flexibility with high and long-lasting antistatic performance - OSAKA, Japan, October 08, 2026--(BUSINESS WIRE)--Gunze Limited (Headquarters: Osaka, Japan; Presid…
Turning every area of a store into a place for advertising, promotions, and customer communication without power wiring or extensive installation work Featuring a broad lineup ranging from A1-sized large-format E-Paper Signage to full-colo…
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Bayer Aktiengesellschaft (BAYRY) or Roche Holding AG (RHHBY). But which of these two companies is the best option for those looking for unde…
Energy prices remain stubbornly high, bond yields are pushing up the cost of capital, and debt worries keep flashing across headlines. That mix is pushing many investors to rethink where to look for steadier income and potentially more res…
— Successful Production of High-Purity, Low-Activation Vanadium Alloy Forgings and Processed Materials Marks Next Phase Toward Commercialization of Blanket Development — TOKYO, October 07, 2026--(BUSINESS WIRE)--Kyoto Fusioneering, Ltd. ("…
Company Logo EV Magnet Report Finds Electric Buses & Trucks Hold the Largest Share as Rare-Earth Supply Concentration and Magnet Recycling Reshape the Competitive Landscape Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "EV Magnet Market by Mag…
Sanoma Corp Sanoma Corporation, Press Release, 7 October 2026 at 11:00 a.m. EET Sanoma will publish its Q3 2026 Interim Report on 28 October Sanoma will publish its Interim Report for 1 January–30 September 2026 on Wednesday 28 October 202…
Aspo Plc Aspo Plc Stock Exchange Release October 7, 2026 at 9.30 EET Proposals to the Extraordinary General Meeting of Aspo Plc: Composition of the future Boards of Directors of ESL Shipping Group Plc and Telko Group Plc (currently Aspo Pl…
Bayer (XTRA:BAYN) has put a US$2.2b price tag on a new pharmaceutical manufacturing hub in New Albany, Ohio, a long-horizon project aimed at specialty treatments in oncology, cardiovascular, and renal care. Bayer's latest share price of €4…
The Parkinson's disease market is expected to grow steadily, driven by the recent approval of AbbVie's JUVMO along with the rising prevalence of the disease, particularly among the aging population. Increasing disease awareness, improved d…
Apollo Global Management President Jim Zelter says compute and energy will remain bottlenecks as the artificial intelligence investment boom accelerates. Speaking with Bloomberg's Francine Lacqua, Zelter discusses Apollo's exposure to AI a…
Expanded collaboration supports continued Canadian access to Bayer medicines across cardiovascular and women's health portfolios. MISSISSAUGA, ON, Oct. 6, 2026 /CNW/ -- Mint Pharmaceuticals Inc. is pleased to announce the expansion of its…
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Baxter International (BAX) is a stock that can certainly grab the attention of many investors, but do its recent returns co…
Albemarle Corporation ALB remains committed to paying down debt and strengthening its balance sheet. The company paid down $1.3 billion of outstanding debt in March 2026, reducing annual interest expense by roughly $60 million. This follow…
Investing.com -- Goldman Sachs downgraded German consumer products company Beiersdorf to "sell" from "neutral" on Tuesday and cut its 12-month price target to €73 from €82, saying a recovery in the Nivea brand could take longer than expect…
Investing.com -- Shares in Wienerberger fell as much as 4.8% on Tuesday after the building materials maker cut its 2026 operating EBITDA guidance, citing weaker-than-expected construction activity and higher energy, raw-material and logist…
Currency swings, climbing French bond yields and fresh political noise from Paris and Madrid have pushed eurozone nerves back to the surface, yet that stress can sometimes hand patient dividend investors an opening. When sentiment sours, d…
Leadership change at CTS Eventim KGaA CTS Eventim KGaA (XTRA:EVD) is in focus after Chief Financial Officer Dr. William Willms left his role on 30 September 2026, with Senior Vice President Finance Dr. Philipp Knigge stepping in on an inte…
Investing.com -- Goldman Sachs expects strong quarterly results from several European utility companies, with RWE, Naturgy, Enel, and EDP positioned to potentially exceed their full-year guidance. The investment bank highlights trading act…
Marie Brizard Wine & Spirits MONTHLY DECLARATION OF THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES (ARTICLE L233-8II THE COMMERCIAL CODE and 223-16 OF THE GENERAL REGULATIONS OF THE FINANCIAL MARKETS AUTHORITY (AMF)) Charenton-le-Pont, 5 Oct…
Pursuant to Article L. 233-8 of the French Commercial Code and Article 223-16 of the General Regulations of the French Autorité des marchés financiers PARIS, October 05, 2026--(BUSINESS WIRE)--Regulatory News: Pierre & Vacances-Center Parc…
Aktieselskabet Schouw & Co. Schouw & Co. share buy-back programme, week 40 2026 On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schou…
Investing.com -- J.P. Morgan on Monday put Givaudan on Positive Catalyst Watch ahead of its Oct. 13 third-quarter results, expecting organic sales growth of 6.7%, above consensus of about 5%. Before you buy NVIDIA: our AI model's stock pic…
SALEM, N.H., October 05, 2026--(BUSINESS WIRE)--Analogic Corporation ("Analogic"), Altaris, LLC, and Leidos, Inc. (NYSE: LDOS) today announced the completion of the previously announced transaction combining Analogic with Leidos' Security…
Investing.com -- Barclays on Monday upgraded Givaudan to "overweight" from "equal weight" and raised its price target by 12% to CHF 3,850, citing stronger growth prospects for its Taste & Wellbeing business. Before you buy NVIDIA: our AI m…